Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people

BACKGROUND: There is uncertainty about the associations of angiotensive enzyme (ACE) inhibitor and angiotensin receptor blocker (ARB) drugs with COVID-19 disease. We studied whether patients prescribed these drugs had altered risks of contracting severe COVID-19 disease and receiving associated inte...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Heart
Main Authors: Hippisley-Cox, Julia, Young, Duncan, Coupland, Carol, Channon, Keith M, Tan, Pui San, Harrison, David A, Rowan, Kathryn, Aveyard, Paul, Pavord, Ian D, Watkinson, Peter J
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Special Populations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509391/
https://ncbi.nlm.nih.gov/pubmed/32737124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2020-317393
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados